- Home
- CARM vs AMBO Comparison
CARM vs AMBO Comparison
Compare CARM & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARM
- AMBO
- Stock Information
- Founded
- CARM 2016
- AMBO 2000
- Country
- CARM United States
- AMBO United States
- Employees
- CARM N/A
- AMBO N/A
- Industry
- CARM Biotechnology: Pharmaceutical Preparations
- AMBO Other Consumer Services
- Sector
- CARM Health Care
- AMBO Real Estate
- Exchange
- CARM Nasdaq
- AMBO Nasdaq
- Market Cap
- CARM 12.1M
- AMBO 11.3M
- IPO Year
- CARM N/A
- AMBO 2010
- Fundamental
- Price
- CARM $0.26
- AMBO $3.54
- Analyst Decision
- CARM Hold
- AMBO
- Analyst Count
- CARM 5
- AMBO 0
- Target Price
- CARM $0.90
- AMBO N/A
- AVG Volume (30 Days)
- CARM 1.1M
- AMBO 9.3K
- Earning Date
- CARM 11-06-2025
- AMBO 08-05-2025
- Dividend Yield
- CARM N/A
- AMBO N/A
- EPS Growth
- CARM N/A
- AMBO N/A
- EPS
- CARM N/A
- AMBO 0.69
- Revenue
- CARM $10,767,000.00
- AMBO $9,699,000.00
- Revenue This Year
- CARM N/A
- AMBO N/A
- Revenue Next Year
- CARM N/A
- AMBO N/A
- P/E Ratio
- CARM N/A
- AMBO $5.17
- Revenue Growth
- CARM N/A
- AMBO 23.73
- 52 Week Low
- CARM $0.14
- AMBO $1.25
- 52 Week High
- CARM $1.27
- AMBO $5.55
- Technical
- Relative Strength Index (RSI)
- CARM 44.09
- AMBO 49.30
- Support Level
- CARM $0.24
- AMBO $3.47
- Resistance Level
- CARM $0.27
- AMBO $3.67
- Average True Range (ATR)
- CARM 0.03
- AMBO 0.22
- MACD
- CARM -0.00
- AMBO -0.04
- Stochastic Oscillator
- CARM 26.11
- AMBO 37.27
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
About AMBO Ambow Education Holding Ltd.
Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.